This site is intended for healthcare professionals only
LoginRegister

Medicine Dialogues

FDA

FDA Expands Approval of Belzutifan for Treatment of pheochromocytoma or paraganglioma

The US food and Drug Administration (FDA) has expanded the approval of Belzutifan (Welireg) to treat specific types of pheochromocytoma or...
View All

Latest News and Guidelines

Rare Case Links Apixaban to Severe Periorbital Dermatitis: Highlights Need for Vigilance in Dermatological Reactions

Rare Case Links Apixaban to Severe Periorbital Dermatitis: Highlights Need for Vigilance in...

Bariatric Surgery Reduces Risk of CRS and Sinus Surgeries by Up to 48% in Obese Patients: Study

Bariatric Surgery Reduces Risk of CRS and Sinus Surgeries by Up to 48% in Obese Patients: Study

BioNTech to buy CureVac in USD 1.25 billion all-stock deal

GSK to acquire liver disease drug Efimosfermin for up to USD 2 billion

Indoco Remedies arm launches heart attack drug Ticagrelor filmcoated in UK

USFDA clears Alembic Pharma cardio drug Rivaroxaban, launch expected in next year

First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

Merck, Daiichi Sankyo Ifinatamab deruxtecan granted Breakthrough Therapy Designation by USFDA for pretreated extensive-stage small cell lung cancer

Merck scores USFDA OK for Welireg for 12 years and older with pheochromocytoma or paraganglioma

View All
X